Additionally, the conolidine molecule didn't interact with the classical receptors, meaning that it wouldn't compete versus opioid peptides to bind to these receptors.In 2011, the Bohn lab famous antinociception in opposition to both chemically induced and inflammation-derived ache, and experiments indicated deficiency of opioid receptor modulation